Zhejiang Jingning Oujiang Capsule Co., Ltd. announced that it will receive CNY 8,920,000 in an equity round of funding on October 27, 2021. The transaction will include participation from returning investor Zhejiang Wecome Pharmaceutical Company Limited for CNY 6,244,000, Wang Shiguo for CNY 2,140,800, and Wang Linsu for CNY 535,200 and retain their stakes of 70%, 24%, and 6% respectively. The transaction has been approved by the board of directors of Zhejiang Wecome Pharmaceutical Company Limited in its third meeting of the third board of directors. Pursuant to the transaction, the registered capital of the company will increase from CNY 1,080,000 to CNY 10,000,000. On November 1, 2021, the company announced that it has completed the industrial and commercial change registration procedures for the above-mentioned capital increase, and obtained a business license issued by the Jingning She Autonomous County Market Supervision Administration.